Tuberculosis 2017 is one of the important microbiological conferences that bring together clinicians, researchers, and other public health planners/association committees or professionals. Tuberculosis research is at its peak, mainly as discoveries in the lab are being executed into treatments in a more targeted and precise manner.
Tuberculosis 2017 provides two days of robust discussions on methods and strategies related to symptoms and management of Tuberculosis as well as explore new ideas and concepts on a global scale to reduce the airborne disease and the topics include Tuberculosis complications, Treatment and therapies for tuberculosis, Advancement in Treatment and Diagnosis, Present scenario and risk factor of Tuberculosis, Clinical trials in mycobacteria, TB Education and Research. The conference invites TB surgeons, TB associated camps and all the eminent researchers and experts in the field of Infectious Diseases. The conference welcomes the participation of researchers and delegates from TB Health care sectors to the conference, which is a perfect platform to network, share knowledge and views through poster, interactive keynote and plenary sessions to discuss improving the current therapies and exploring new approaches.
Allied Academic officially welcomes you to attend the Global Summit on Tuberculosis and Mycobacteria during Aug 3-4, 2017 at San Francisco, USA.
Tuberculosis 2017 highlights the theme “Elucidating Mycobacterial Resistance & Driving sustainability for TB control”.